Tejas Savant

Stock Analyst at Morgan Stanley

(2.24)
# 1,494
Out of 4,333 analysts
181
Total ratings
42.06%
Success rate
-4.82%
Average return

29 Stocks

Hologic
Nov 13, 2023
Maintains: Equal-Weight
Price Target: $86$82
Current: $76.11
Upside: +7.74%
Veracyte
Nov 10, 2023
Maintains: Underweight
Price Target: $23$22
Current: $22.57
Upside: -2.53%
Natera
Nov 10, 2023
Maintains: Overweight
Price Target: $70$68
Current: $70.69
Upside: -3.81%
Maravai LifeSciences Holdings
Nov 9, 2023
Maintains: Overweight
Price Target: $12$11
Current: $8.25
Upside: +33.33%
Cytek Biosciences
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $8$7
Current: $8.55
Upside: -18.13%
NeoGenomics
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $16$17
Current: $16.27
Upside: +4.49%
IQVIA Holdings
Nov 3, 2023
Maintains: Overweight
Price Target: $240$225
Current: $246.95
Upside: -8.89%
Avantor
Oct 30, 2023
Maintains: Overweight
Price Target: $24$22
Current: $24.34
Upside: -9.61%
Thermo Fisher
Oct 26, 2023
Maintains: Overweight
Price Target: $600$545
Current: $565.02
Upside: -3.54%
Pacific Biosciences of California
Oct 24, 2023
Maintains: Equal-Weight
Price Target: $13$10
Current: $5.23
Upside: +91.20%
Olink Holding AB (publ)
Oct 24, 2023
Maintains: Equal-Weight
Price Target: $18$26
Current: $22.01
Upside: +18.15%
Akoya Biosciences
Oct 24, 2023
Maintains: Overweight
Price Target: $15$8
Current: $5.59
Upside: +43.11%
Adaptive Biotechnologies
Oct 24, 2023
Maintains: Equal-Weight
Price Target: $13$10
Current: $4.02
Upside: +148.76%
Catalent
Aug 30, 2023
Maintains: Overweight
Price Target: $52$55
Current: $58.63
Upside: -6.19%
PhenomeX
Aug 18, 2023
Upgrades: Equal-Weight
Price Target: $1
Current: $1.00
Upside: +0.19%
Cryoport
Aug 17, 2023
Initiates: Equal-Weight
Price Target: $16
Current: $16.28
Upside: -1.69%
10x Genomics
Aug 7, 2023
Reiterates: Overweight
Price Target: $65
Current: $45.46
Upside: +42.98%
Nautilus Biotechnology
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $6
Current: $2.79
Upside: +115.05%
SOPHiA GENETICS
May 10, 2023
Maintains: Overweight
Price Target: $11$10
Current: $4.80
Upside: +108.25%
Rapid Micro Biosystems
Mar 7, 2023
Reiterates: Equal-Weight
Price Target: $2.75
Current: $0.97
Upside: +184.97%
Personalis
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $11$5
Current: $1.26
Upside: +296.83%
Seer, Inc.
Feb 21, 2023
Maintains: Equal-Weight
Price Target: $11$10
Current: $1.55
Upside: +547.25%
Guardant Health
Feb 21, 2023
Maintains: Overweight
Price Target: $80$73
Current: $19.76
Upside: +269.43%
Illumina
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $240$225
Current: $134.20
Upside: +67.66%
Ginkgo Bioworks Holdings
Oct 4, 2022
Initiates: Equal-Weight
Price Target: $5
Current: $1.34
Upside: +274.53%
Cue Health
Aug 11, 2022
Maintains: Equal-Weight
Price Target: $10$8
Current: $0.24
Upside: +3,247.28%
Charles River Laboratories International
Aug 4, 2022
Downgrades: Equal-Weight
Price Target: $350$250
Current: $248.86
Upside: +0.46%
Biodesix
May 12, 2022
Maintains: Equal-Weight
Price Target: $7$5
Current: $1.49
Upside: +236.70%
Abcam
Mar 15, 2022
Maintains: Equal-Weight
Price Target: $21$20
Current: $23.99
Upside: -16.63%